See also this year's filing and all EDGAR filings for this company.
PDF Report 0001061027_2012_Viracta_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001061027, Viracta Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 45,665,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 74,000 |
| 3 | remainder_Assets | 130,000 |
| 4 | LiabilitiesCurrent | 8,383,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,303,000 |
| 9 | ResearchAndDevelopmentExpense | 22,563,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 5,000,000 |
| 12 | remainder_NetIncome | 5,725,000 |
| 13 | remainder_ComprehensiveNetIncome | 34,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 45,869,000 |
| 1 | Liabilities | 8,383,000 |
| 2 | Expenses | 30,866,000 |
| 3 | Revenues | 5,000,000 |
| 4 | StockholdersEquity | 37,486,000 |
| 5 | NetIncome | -20,141,000 |
| 6 | ComprehensiveNetIncome | -20,124,000 |
| 7 | BaseVar | 47,938,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.27 |
| 9 | EconomicCapitalRatio | 3.20 |
Edgar->Model Mapping
Feature Distribution
